News

Screening of patients for the TT-06 clinical trial, sponsored by Alk-Abello, has been properly completed

Our Study Site is open to recruiting patients for a phase III clinical trial in order to evaluate the efficacy and safety of a new oral medicine for patients with moderate or severe Crohn's disease, sponsored by the pharmaceutical company Selgene, Switzerland.

A new visit to the opening of the center: GALACTIC-1 phase IIb clinical trial involving patients with Idiopathic Pulmonary Fibrosis, sponsored by the pharmaceutical company Galecto Bayotek AB, Denmark

The Site's participation in three clinical trials of drugs for the treatment of ulcerative colitis was approved by the sponsor of the study - the pharmaceutical company Pfizer.